Emile Voest
25-04-2023
Just one WGS test is enough to reveal everything you need to know to provide a patient with metastatic cancer with targeted treatment, be it a registered therapy or part of a research trial.
Back to newsMore news
New study using Hartwig Medical Foundation data maps how breast cancer’s genetic makeup shifts when it spreads
16-07-2026
Analysis of nearly 1,300 tumor genomes across ten genomic subtypes points to candidate drug targets and biomarkers for metastatic breast …
Whole genome sequencing to improve individual cancer treatment in Finland
10-07-2020
Since August 2019, Docrates, a private cancer center in Finland, uses the whole genome sequencing test from Hartwig Medical Foundation to …
In the media: Rarity – Personalised cancer treatment – fact not fiction
28-02-2022
Imagine a world in which each person’s cancer is treated with a personalised, targeted medical treatment regimen. A world in …
In our profession, we need to know everything about the patient, but we also want to know as much as possible about the patient’s tumor.
Medical oncologist, Elisabeth-TweeSteden Hospital